Laddar...
Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives
Patients with advanced non-small cell lung cancer receive first-line therapy with chemotherapy, targeted therapies in case of tumors with driver mutations, and more recently also immune checkpoint inhibitors. Important controversies include the role of targeted therapies in combination with chemothe...
Sparad:
| I publikationen: | Memo |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer Vienna
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006273/ https://ncbi.nlm.nih.gov/pubmed/29983826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-018-0408-y |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|